Medicare Payment Advisory Commission Nomination Letters, 81503 [2011-33226]
Download as PDF
<![CDATA[
Federal Register / Vol. 76, No. 249 / Wednesday, December 28, 2011 / Notices
products subject to this order are as
follows.
A. Registrations Listed in Table 1 of
Unit II
The registrants may continue to sell
and distribute existing stocks of
products listed in Table 1 of Unit II.
until December 28, 2012, which is 1
year after the publication of the
Cancellation Order in the Federal
Register. Thereafter, the registrants are
prohibited from selling or distributing
products listed in Table 1, except for
export in accordance with FIFRA
section 17, or proper disposal. Persons
other than the registrants may sell,
distribute, or use existing stocks of
products listed in Table 1 of Unit II.
until existing stocks are exhausted,
provided that such sale, distribution, or
use is consistent with the terms of the
previously approved labeling on, or that
accompanied, the cancelled products.
srobinson on DSK4SPTVN1PROD with NOTICES
B. Registrations Listed in Table 2 of Unit
II Except CA970032 and FL970008
The registrants may sell and distribute
existing stocks of these products until
January 15, 2012, 1 year after the date
on which the maintenance fee was due.
Thereafter, the registrants are prohibited
from selling or distributing the
pesticides identified in Table 2 of Unit
II., except for export consistent with
FIFRA section 17 or for proper disposal.
Persons other than registrants are
allowed to sell, distribute, or use
existing stocks until such stocks are
exhausted, provided that such sale,
distribution, or use is consistent with
the terms of the previously approved
labeling on, or that accompanied, the
cancelled products.
C. Registration Numbers CA970032 and
FL970008
Mitigation measures included as part
of the Reregistration Eligibility Decision
(RED) for methyl bromide are being
implemented in two phases. The first
phase of mitigation is required to be
placed on all product labels in 2011.To
ensure that all methyl bromide products
in the marketplace have the same
protections at the same time, the
following are the existing stocks
provisions for the cancellation of
registration numbers CA970032 and
FL970008. The registrants may sell and
distribute existing stocks of these
products until December 31, 2011.
Thereafter, the registrants are prohibited
from selling and distributing the
pesticides identified in Table 2 of Unit
II., except for export consistent with
FIFRA section 17 or for proper disposal.
Persons other than registrants are
allowed to sell and distribute existing
VerDate Mar<15>2010
18:22 Dec 27, 2011
Jkt 226001
81503
stocks through April 30, 2012. After
December 28, 2011, remaining stocks
may be used until such stocks are
exhausted, provided that such use is
consistent with the terms of the
previously approved labeling on, or that
accompanied, the cancelled products.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
List of Subjects
Agency Information Collection
Activities: Submission for OMB
Review; Comment Request
Environmental protection, Pesticides
and pests.
Dated: November 17, 2011.
Richard P. Keigwin, Jr.
Director, Pesticide Re-evaluation Division,
Office of Pesticide Programs.
[FR Doc. 2011–33252 Filed 12–27–11; 8:45 am]
BILLING CODE 6560–50–P
GOVERNMENT ACCOUNTABILITY
OFFICE
Medicare Payment Advisory
Commission Nomination Letters
Government Accountability
Office (GAO).
AGENCY:
ACTION:
Notice on letters of nomination.
The Balanced Budget Act of
1997 established the Medicare Payment
Advisory Commission (MedPAC) and
gave the Comptroller General
responsibility for appointing its
members. For appointments to MedPAC
that will be effective May 1, 2012, I am
announcing the following: Letters of
nomination should be submitted
between January 1 and March 8, 2011,
to ensure adequate opportunity for
review and consideration of nominees
prior to the appointment of new
members.
SUMMARY:
GAO:
MedPACappointments@gao.gov. GAO:
441 G Street NW., Washington, DC
20548. MedPAC: 601 New Jersey
Avenue NW., Suite 9000, Washington,
DC 20001.
ADDRESSES:
FOR FURTHER INFORMATION CONTACT:
GAO: Office of Public Affairs, (202)
512–4800. 42 U.S.C. 1395b–6.
Gene L. Dodaro,
Comptroller of the United States.
[FR Doc. 2011–33226 Filed 12–27–11; 8:45 am]
BILLING CODE 1610–02–M
PO 00000
Frm 00039
Fmt 4703
Sfmt 4703
Centers for Medicare & Medicaid
Services
[Document Identifier CMS–10249 and CMS–
10409]
Centers for Medicare &
Medicaid Services, HHS.
In compliance with the requirement
of section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995, the
Centers for Medicare & Medicaid
Services (CMS), Department of Health
and Human Services, is publishing the
following summary of proposed
collections for public comment.
Interested persons are invited to send
comments regarding this burden
estimate or any other aspect of this
collection of information, including any
of the following subjects: (1) The
necessity and utility of the proposed
information collection for the proper
performance of the Agency’s function;
(2) the accuracy of the estimated
burden; (3) ways to enhance the quality,
utility, and clarity of the information to
be collected; and (4) the use of
automated collection techniques or
other forms of information technology to
minimize the information collection
burden.
1. Type of Information Collection
Request: Revision of a currently
approved collection; Title of
Information Collection: Administrative
Requirements for Section 6071 of the
Deficit Reduction Act; Use: Under
section 6071 of the Deficit Reduction
Act of 2005 (Pub. L. 109–171)
subsection (c), the Secretary may require
States to meet requirements and provide
additional information, provisions, and
assurances. Through the Operational
Protocol, States provide the
requirements, information, provisions
and assurances which, following CMS
approval, States may enroll individuals
in the State’s demonstration program or
begin to claim for service dollars. The
Act also requires the Money Follows the
Person Rebalancing Demonstration
(MFP) program be evaluated to
determine program effectiveness. One
aspect of the evaluation is determining
participant quality of life and how the
program affects quality of life. Medicaid
enrollees who participate in the MFP
program are expected to have need for
long-term care services for the rest of
their lives and are a particularly
vulnerable population if the community
setting cannot adequately meet their
AGENCY:
E:\FR\FM\28DEN1.SGM
28DEN1
]]>Agencies
[Federal Register Volume 76, Number 249 (Wednesday, December 28, 2011)]
[Notices]
[Page 81503]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-33226]
=======================================================================
-----------------------------------------------------------------------
GOVERNMENT ACCOUNTABILITY OFFICE
Medicare Payment Advisory Commission Nomination Letters
AGENCY: Government Accountability Office (GAO).
ACTION: Notice on letters of nomination.
-----------------------------------------------------------------------
SUMMARY: The Balanced Budget Act of 1997 established the Medicare
Payment Advisory Commission (MedPAC) and gave the Comptroller General
responsibility for appointing its members. For appointments to MedPAC
that will be effective May 1, 2012, I am announcing the following:
Letters of nomination should be submitted between January 1 and March
8, 2011, to ensure adequate opportunity for review and consideration of
nominees prior to the appointment of new members.
ADDRESSES: GAO: MedPACappointments@gao.gov. GAO: 441 G Street NW.,
Washington, DC 20548. MedPAC: 601 New Jersey Avenue NW., Suite 9000,
Washington, DC 20001.
FOR FURTHER INFORMATION CONTACT: GAO: Office of Public Affairs, (202)
512-4800. 42 U.S.C. 1395b-6.
Gene L. Dodaro,
Comptroller of the United States.
[FR Doc. 2011-33226 Filed 12-27-11; 8:45 am]
BILLING CODE 1610-02-M
